WCM Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$876M Sell
10,826,014
-439,700
-4% -$35.5M 1.59% 22
2026
Q1
$966M Buy
+11,265,714
New +$1.08B 2.2% 18
2025
Q2
Sell
-46,652
Closed -$4.09M 264
2025
Q1
$4.09M Sell
46,652
-1,288
-3% -$115K 0.01% 188
2024
Q4
$3.82M Buy
47,940
+28,473
+146% +$2.46M 0.01% 198
2024
Q3
$1.74M Buy
+19,467
New +$1.64M ﹤0.01% 219
2022
Q1
Sell
-7,473
Closed -$773K 208
2021
Q4
$773K Buy
7,473
+450
+6% +$52.1K ﹤0.01% 190
2021
Q3
$880K Buy
7,023
+255
+4% +$33K ﹤0.01% 183
2021
Q2
$840K Buy
6,768
+1,954
+41% +$245K ﹤0.01% 176
2021
Q1
$569K Buy
4,814
+2,700
+128% +$316K ﹤0.01% 171
2020
Q4
$248K Buy
+2,114
New +$233K ﹤0.01% 191

Other funds holding MDT

WCM Investment Management's MDT Position: Q2 2026 in Review

WCM Investment Management reduced its Medtronic (MDT) stake by 3.9% in Q2 2026, selling an estimated $35.5M and leaving 10,826,014 shares worth $876M. The position accounts for 1.59% of the portfolio, ranked #22.

WCM Investment Management first reported a position in MDT in Q4 2020 and has held it in 10 quarters since. The position peaked at $966M in Q1 2026. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • WCM Investment Management held 10,826,014 shares of Medtronic worth $876M as of Q2 2026.
  • WCM Investment Management sold 439,700 Medtronic shares in Q2 2026, an estimated $35.5M.
  • Medtronic made up 1.59% of WCM Investment Management's portfolio in Q2 2026, its #22 holding.
  • WCM Investment Management first reported a position in Medtronic in Q4 2020 and has held it in 10 quarters since.
  • WCM Investment Management's Medtronic position peaked at $966M in Q1 2026.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.